Breast Cancer Research

Wasserman Schultz helped lead fellow House Democrats in passing robust and essential appropriations bills that achieve significant victories for families across the nation, especially in South Florida. Read more

My story, like many others, begins with the words “You have breast cancer.” Read more

“Reauthorizing the EARLY Act means that we will continue the vital work of educating young and higher risk women about their breast health and direct their attention to this deadly disease." Read more

Today, Congresswoman Debbie Wasserman Schultz (FL-23) and Senator Tim Kaine (D-VA) sent a bicameral letter to Health and Human Services Secretary Alex Azar, signed by 52 of their House and Senate colleagues, questioning the Trump Administration’s decision to eliminate the National Guideline Clearinghouse (NGC) website, www.Guideline.gov. For the past 20 years, the NGC database has provided evidence-based best practices for treating common medical conditions to clinicians and patients at no cost.... Read more

Wasserman Schultz Lauds Critical Omnibus Act Funding and Rejection of Trump Budget (Washington, D.C.) – U.S. Rep. Wasserman Schultz (FL-23) was pleased that critical national and South Florida investments are contained in the Omnibus Appropriations Act of 2018, and in voting for it, she applauded the Democratss’ effort to defeat of numerous attacks on environmental, worker and women’s health rights that Republicans sought to include in the $1.3 trillion spending plan. “This Omnibus is far from p... Read more

"I know that early detection saves lives and if you cut out a decade between when women are 40 and 50 years and they don’t begin screening starting at 40 then you know that we’re going to lose thousands and thousands more women than we would if they had access to that screening beginning at 40," the congresswoman said. Read more